Identification of diagnostic and prognostic biomarkers for tuberculosis based on plasma proteomics
PLOS One · 2025
DOI: 10.1371/journal.pone.0339558 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PLOS One, 2025. Verfasst von Yan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Wuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, The Hubei Branch of the National Clinical Research Center for…. Hauptthemen laut MEDLINE: Latent Tuberculosis, Tuberculosis, Mycobacterium Infections, Nontuberculous, Proteomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Science and Technology Health Project of the Health Commission of Hubei Province, Basic Applied Research Project of Wuhan Science and Technology Bureau.
Abstract (Originalsprache)
Background
The differential diagnosis between Tuberculosis (TB) and Non-tuberculous Mycobacteria (NTM) has historically been constrained by the inadequate sensitivity and specificity of current diagnostic methods. Furthermore, distinguishing between Active Tuberculosis (ATB) and Latent Tuberculosis Infection (LTBI) poses significant challenges. This study aims to develop a molecular differentiation system for ATB, LTBI, and NTM by integrating plasma proteomics with multi-dimensional analytical techniques, while also exploring key biomarkers associated with disease progression and treatment response.
Methods
Using label-free quantitative technology, we conducted a plasma proteomics analysis across five groups: ATB, LTBI, NTM, Cured Patients (CPs), and Healthy Donors (HD). Differentially Expressed Proteins (DEPs) were identified through screening (FC > 1.5 or
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Central Laboratory, Wuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control, The Hubei Branch of the National Clinical Research Center for Infectious Disease, Wuhan, Hubei, China.
- Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Laboratory Department, Shenzhen Baoan District People's Hospital, Shenzhen, Guangdong, China.
- National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong, China.
ORCID-Profile: Peng Liu
Förderung
- the National Natural Science Foundation of China
- the Science and Technology Health Project of the Health Commission of Hubei Province
- Basic Applied Research Project of Wuhan Science and Technology Bureau
- Science and Technology Project of Shenzhen
- Bao'an District Medical Association
- Wuhan Pulmonary Hospital Research Fund
Zitieren
APA
Hu, Y., Quan, C., Zhou, Y., Liang, S., Wang, X., Li, J., Liu, W., Xu, Y., & Liu, P. (2025). Identification of diagnostic and prognostic biomarkers for tuberculosis based on plasma proteomics. PLOS One. https://doi.org/10.1371/journal.pone.0339558
Vancouver
Hu Y, Quan C, Zhou Y, Liang S, Wang X, Li J, et al. Identification of diagnostic and prognostic biomarkers for tuberculosis based on plasma proteomics. PLOS One. 2025. doi:10.1371/journal.pone.0339558
BibTeX
@article{Hu2025,
author = {Hu, Yan and Quan, Chao and Zhou, Yuanyuan and Liang, Shangyan and Wang, Xuan and Li, Jun and Liu, Wenqi and Xu, Yuzhong and Liu, Peng},
title = {Identification of diagnostic and prognostic biomarkers for tuberculosis based on plasma proteomics},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0339558}
}
EUVIMED